Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2018.10.17, US 201862747080 P
2018.11.26, US 201862771570 P
ANDREW KING ET AL: "Mixed tau, TDP-43 and p62 pathology in FTLD associated with arepeat expansion and p.Ala239Thr(tau) variant", ACTA NEUROPATHOLOGICA, SPRINGER, BERLIN, DE, vol. 125, no. 2, 28 September 2012 (2012-09-28), pages 303-310, XP035167370, ISSN: 1432-0533, DOI: 10.1007/S00401-012-1050-0 (B1)
ÖZALP BURHAN ET AL: "The effect of coenzyme Q10on venous ischemia reperfusion injury", JOURNAL OF SURGICAL RESEARCH, ACADEMIC PRESS INC., SAN DIEGO, CA, US, vol. 204, no. 2, 7 May 2016 (2016-05-07), pages 304-310, XP029706596, ISSN: 0022-4804, DOI: 10.1016/J.JSS.2016.04.075 (B1)
HIRANO A: "AMYOTROPHIC LATERAL SCLEROSIS AND PARKINSONISM-DEMENTIA COMPLEX ON GUAM: IMMUNOHISTOCHEMICAL STUDIES", KEIO JOURNAL OF MEDICINE, TOKYO, JP, vol. 41, no. 1, 1 March 1992 (1992-03-01), pages 6-09, XP000990014, ISSN: 0022-9717 (B1)
KEVIN F BIENIEK ET AL: "Tau pathology in frontotemporal lobar degeneration withhexanucleotide repeat expansion", ACTA NEUROPATHOLOGICA, SPRINGER, BERLIN, DE, vol. 125, no. 2, 28 September 2012 (2012-09-28), pages 289-302, XP035167374, ISSN: 1432-0533, DOI: 10.1007/S00401-012-1048-7 (B1)
LILLO ET AL: "Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum", AMYOTROPHIC LATERAL SCLEROSIS, vol. 13, 2012, pages 102-109, (B1)
MOSZCZYNSKI ET AL: "PATHOLOGIC THR175 TAU PHOSPHORYLATION IN CTE AND CTE WITH ALS", NEUROLOGY, vol. 90, no. 5, 2018, pages e380-e387, (B1)
MURAT KALAYCI ET AL: "Effect of Coenzyme Q10 on ischemia and neuronal damage in an experimental traumatic brain-injury model in rats", BMC NEUROSCIENCE, BIOMED CENTRAL, LONDON, GB, vol. 12, no. 1, 29 July 2011 (2011-07-29), page 75, XP021104785, ISSN: 1471-2202, DOI: 10.1186/1471-2202-12-75 (B1)
NAHED EL-NAJJAR ET AL: "The chemical and biological activities of quinones: overview and implications in analytical detection", PHYTOCHEMISTRY REVIEWS, KLUWER ACADEMIC PUBLISHERS, DO, vol. 10, no. 3, 20 April 2011 (2011-04-20) , pages 353-370, XP019933550, ISSN: 1572-980X, DOI: 10.1007/S11101-011-9209-1 (B1)
SIEGEL D ET AL: "The reduction of [alpha]-tocopherolquinone by human NAD(P)H: Quinone oxidoreductase: The role of [alpha]-tocopherolhydroquinone as a cellular antioxidant", MOLECULAR PHARMACOLOGY 199708 US, vol. 52, no. 2, August 1997 (1997-08), pages 300-305, ISSN: 0026-895X (B1)
US-A1- 2007 072 943 (B1)
US-A1- 2010 063 161 (B1)
VINTILESCU ET AL: "The Neurotoxic Tau45-230 Fragment Accumulates in Upper and Lower Motor Neurons in Amyotrophic Lateral Sclerosis Subjects", MOLECULAR MEDICINE, vol. 22, 2016, pages 477-486, (B1)
WENCHENG YANG, MICHAEL J STRONG: "Widespread neuronal and glial hyerphosphorylated tau deposition in ALS with cognitive impairment", AMYOTROPHIC LATERAL SCLEROSIS, vol. 13, 2012, pages 178-193, (B1)
WO-A1-2012/170773 (B1)
WO-A1-2018/191732 (B1)
YANG ET AL: "Tau protein aggregation in the frontal and entorhinal cortices as a function of aging", DEVELOPMENTAL BRAIN RESEARCH, ELSEVIER SCIENCE BV, AMSTERDAM, NL, vol. 156, no. 2, 12 May 2005 (2005-05-12), pages 127-138, XP005024773, ISSN: 0165-3806 (B1)
YANG W ET AL: "Microtubule-associated tau protein positive neuronal and glial inclusions in ALS", NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS , PHILADELPHIA, US, vol. 61, no. 12, 1 January 2003 (2003-01-01), pages 1766-1773, XP003014131, ISSN: 0028-3878 (B1)
HE HUA ET AL: "Amyotrophic Lateral Sclerosis-associated GGGGCC repeat expansion promotes Tau phosphorylation and toxicity", NEUROBIOLOGY OF DISEASE, ELSEVIER, AMSTERDAM, NL, vol. 130, 6 June 2019 (2019-06-06), XP085795895, ISSN: 0969-9961, DOI: 10.1016/J.NBD.2019.104493 [retrieved on 2019-06-06] (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3866772)
|
Innkommende
Korrespondanse (Hovedbrev inn)
|
Utgående
EP Formelle mangler
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 6. avg. år (EP) | 2024.09.23 | 2600 | ANAQUA SERVICES | Betalt og godkjent |
Forsinkelsesavgift patent | 2024.02.20 | 700 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 5. avg. år (EP) | 2024.02.20 | 1650 | CPA GLOBAL LIMITED | Betalt og godkjent |
32400366 expand_more expand_less | 2024.01.08 | 5500 | ZACCO NORWAY AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|